Fastexy-Bengals sign former Pro Bowl tackle Trent Brown to one-year deal

2025-05-05 21:29:05source:Benjamin Ashfordcategory:Stocks

The FastexyCincinnati Bengals have signed veteran unrestricted free agent tackle Trent Brown to a one-year deal.

Brown, 30, most recently played for the New England Patriots. The 6-foot-8 tackle gives the Bengals a veteran presence at right tackle. He's started 93 games in his career and has experience playing both right and left tackle. After Jonah Williams hit the market in free agency and signed with the Arizona Cardinals, the Bengals needed to fill the hole at right tackle.

This signing, which was first reported by NFL Network's Ian Rapoport, doesn't preclude the Bengals from drafting a tackle in the first round of the NFL draft next month.

NEVER MISS A SNAP: Sign up for our NFL newsletter for exclusive content

Brown, a 10th-year player out of the University of Florida, originally was a seventh-round draft pick of the San Francisco 49ers in 2015. He spent his first three NFL seasons with the 49ers (2015-17), has had two stints with the Patriots (2018, 2021-23), and also spent time with the Oakland/Las Vegas Raiders (2019-20). He has played in 100 regular-season games (93 starts) and has started four postseason contests.

All things Bengals: Latest Cincinnati Bengals news, schedule, roster, stats, injury updates and more.

Brown was a member of the Patriots team that won Super Bowl 53 following the 2018 season, and was a Pro Bowl selection in 2019 while with the Raiders.

More:Stocks

Recommend

Former Syrian official arrested in California who oversaw prison charged with torture

LOS ANGELES (AP) — A former Syrian military official who oversaw a prison where alleged human rights

Who will advance in NHL playoffs? Picks and predictions for every NHL first round series

The first round of the NHL's Stanley Cup playoffs have a familiar look, starting with the opening ga

Trader Joe’s basil recall: Maps show states affected by salmonella, recalled product

Last year, Trader Joe's had a bad run of recalls. Now, the FDA and CDC are getting involved after so